2495-P: Testosterone Deficiency Promotes Diet-Induced Hepatic Steatosis in Mice
Diabetes · 05.06.2026 · 75 (Supplement_1)
DOI: 10.2337/db26-2495-p ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, erschienen am 05.06.2026. Verfasst von FELIPE SUCUPIRA und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction and Objective: Lifestyle factors and increased consumption of high-fat diets largely contribute to the development of obesity, insulin resistance, type 2 diabetes (T2DM), and cardiovascular diseases. One major consequence of this lifestyle is non-alcoholic fatty liver disease (NAFLD), which affects approximately 30% of adults and up to 10% of children in developed countries. Obesity is also a leading cause of reduced testosterone levels in men, affecting 20-40% of obese individuals compared to only 4-5% in the general male population. This study aimed to evaluate the effects of testosterone on metabolic regulation in male mice.
Methods
Male C57BL/6J mice were chemically castrated using Degarelix (DGX), with or without testosterone replacement therapy (TRT), and fed either a standard diet (SD) or a high-fat diet (HFD; 45% kcal from fat) for 8 weeks, forming six experimental groups.
Results
Low testosterone levels (DGX+HFD) decreased lean mass without altering total body weight or fat mass and did not affect glucose tolerance; however, they promoted hepatic triglyceride accumulation, reduced plasma cholesterol, and impaired VLDL-TG export. Additionally, testosterone deficiency attenuated HFD-induced fasting hyperinsulinemia but modestly elevated serum AST and ALT levels. TRT reversed these effects, restoring lipid export, fasting insulin, and lean-to-fat ratio, although further increasing hepatic enzyme levels.
Conclusion
In conclusion, androgenic hormones play a key role in hepatic lipid metabolism and the insulin response to obesity. Low testosterone mitigates hyperinsulinemia but exacerbates hepatic lipid accumulation, warranting further investigation into the underlying mechanisms. Disclosure F. Sucupira: None. A. Goncalves da Cruz: None. S.L. Matos: None. F.N. Camargo: None. J. Camporez: None. Funding FAPESP (processo:2023/16186-8)
Zitieren
APA
SUCUPIRA, F., CRUZ, A. G. D., MATOS, S. L., CAMARGO, F. N., & CAMPOREZ, J. P. (2026). 2495-P: Testosterone Deficiency Promotes Diet-Induced Hepatic Steatosis in Mice. Diabetes, 75(Supplement_1). https://doi.org/10.2337/db26-2495-p
Vancouver
SUCUPIRA F, CRUZ AGD, MATOS SL, CAMARGO FN, CAMPOREZ JP. 2495-P: Testosterone Deficiency Promotes Diet-Induced Hepatic Steatosis in Mice. Diabetes. 2026;75(Supplement_1). doi:10.2337/db26-2495-p
BibTeX
@article{SUCUPIRA2026,
author = {SUCUPIRA, FELIPE and CRUZ, ALESSANDRA GONCALVES DA and MATOS, SANDRO L. and CAMARGO, FELIPE N.D. and CAMPOREZ, JOAO PAULO},
title = {2495-P: Testosterone Deficiency Promotes Diet-Induced Hepatic Steatosis in Mice},
journal = {Diabetes},
year = {2026},
volume = {75},
number = {Supplement_1},
doi = {10.2337/db26-2495-p}
}
EUVIMED